Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 15,971 | 16,373 | 17,788 | 16,608 | 49,593 |
| Gross Profit | 15,971 | 16,373 | 17,788 | 16,608 | 49,593 |
| Operating Expenses | 31,598 | 31,152 | 32,683 | 32,746 | 52,386 |
| Operating Income | -15,627 | -14,779 | -14,895 | -16,138 | -2,793 |
| Other Income | 73 | 78 | 185 | 459 | 1,087 |
| Pre-tax Income | -15,554 | -14,701 | -14,710 | -15,679 | -1,706 |
| Income Tax | N/A | N/A | N/A | N/A | -13,911 |
| Net Income Continuous | -15,554 | -14,701 | -14,710 | -15,679 | 12,205 |
| Net Income | $-15,554 | $-14,701 | $-14,710 | $-15,679 | $12,205 |
| EPS Basic Total Ops | -0.26 | -0.32 | -0.32 | -0.34 | 0.27 |
| EPS Basic Continuous Ops | -0.26 | -0.32 | -0.32 | -0.34 | 0.27 |
| EPS Diluted Total Ops | -0.26 | -0.31 | -0.32 | -0.34 | 0.26 |
| EPS Diluted Continuous Ops | -0.26 | -0.31 | -0.32 | -0.34 | 0.26 |
| EBITDA(a) | $-14,812 | $-14,012 | $-14,270 | $-15,703 | $-2,283 |